PATENT CLAIM ANALYSIS

Application Number: 16005105
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "443000"]

Abstract:
The invention features sublingual formulations of apomorphine and apomorphine prodrugs, and methods of treating Parkinson's disease, sexual dysfunction, and depressive disorders therewith.

Claim (Index 3):
A pharmaceutical composition in unit dosage form formulated for sublingual administration, wherein said unit dosage form is a film or a strip having a first portion comprising apomorphine particles comprising an acid addition salt of apomorphine and a second portion comprising a pH neutralizing agent.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 94.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12813820', '14963971', '14963910', '14971532', '14684146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.75711699104914
- 35 USC 102 Novelty (BERT): 0.5236567362259077
- Combined Prediction Score: 0.7337709655668169
- Mean Citation Score: 344.708428
- Max Citation Score: 350.6721
- Similarity Product: 310.58442208349703

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test